Durcan MJ - Search Results

1

Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers.

DeVeaugh-Geiss AM, Chen LH, Kotler ML, Ramsay LR, Durcan MJ. DeVeaugh-Geiss AM, et al. Among authors: durcan mj. Clin Ther. 2010 Jun;32(6):1140-8. doi: 10.1016/j.clinthera.2010.06.008. Clin Ther. 2010. PMID: 20637967 Clinical Trial.

2

Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.

Atzori G, Lemmonds CA, Kotler ML, Durcan MJ, Boyle J. Atzori G, et al. Among authors: durcan mj. J Clin Psychopharmacol. 2008 Dec;28(6):667-74. doi: 10.1097/JCP.0b013e31818c9bb8. J Clin Psychopharmacol. 2008. PMID: 19011436 Clinical Trial.

3

The effect of bupropion sustained-release on cigarette craving after smoking cessation.

Durcan MJ, Deener G, White J, Johnston JA, Gonzales D, Niaura R, Rigotti N, Sachs DP. Durcan MJ, et al. Clin Ther. 2002 Apr;24(4):540-51. doi: 10.1016/s0149-2918(02)85130-x. Clin Ther. 2002. PMID: 12017399 Clinical Trial.

4

The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG.

Beaver JD, Long CJ, Cole DM, Durcan MJ, Bannon LC, Mishra RG, Matthews PM. Beaver JD, et al. Among authors: durcan mj. Neuropsychopharmacology. 2011 Aug;36(9):1792-800. doi: 10.1038/npp.2011.53. Epub 2011 May 4. Neuropsychopharmacology. 2011. PMID: 21544072 Free PMC article. Clinical Trial.

5

Impact of prior nicotine replacement therapy on smoking cessation efficacy.

Durcan MJ, White J, Jorenby DE, Fiore MC, Rennard SI, Leischow SJ, Nides MA, Ascher JA, Johnston JA. Durcan MJ, et al. Am J Health Behav. 2002 May-Jun;26(3):213-20. doi: 10.5993/ajhb.26.3.6. Am J Health Behav. 2002. PMID: 12018757 Clinical Trial.

6

Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics.

Cole DM, Beckmann CF, Long CJ, Matthews PM, Durcan MJ, Beaver JD. Cole DM, et al. Among authors: durcan mj. Neuroimage. 2010 Aug 15;52(2):590-9. doi: 10.1016/j.neuroimage.2010.04.251. Epub 2010 May 2. Neuroimage. 2010. PMID: 20441798 Clinical Trial.

7

Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation.

Johnston AJ, Ascher J, Leadbetter R, Schmith VD, Patel DK, Durcan M, Bentley B. Johnston AJ, et al. Drugs. 2002;62 Suppl 2:11-24. doi: 10.2165/00003495-200262002-00002. Drugs. 2002. PMID: 12109932 Review.

8

Bupropion SR for relapse prevention: a "slips-allowed" analysis.

Durcan MJ, Johnston JA, White J, Gonzales D, Sachs DP, Rigotti N, Niaura R. Durcan MJ, et al. Am J Health Behav. 2004 Sep-Oct;28(5):456-63. Am J Health Behav. 2004. PMID: 15482975 Clinical Trial.

9

Effects of gender on relapse prevention in smokers treated with bupropion SR.

Gonzales D, Bjornson W, Durcan MJ, White JD, Johnston JA, Buist AS, Sachs DP, Rigotti NA, Niaura R, Hays JT, Hurt RD. Gonzales D, et al. Among authors: durcan mj. Am J Prev Med. 2002 May;22(4):234-9. doi: 10.1016/s0749-3797(02)00419-1. Am J Prev Med. 2002. PMID: 11988379

10

Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome.

Hurt RD, Wolter TD, Rigotti N, Hays JT, Niaura R, Durcan MJ, Gonzales D, Sachs DP, Johnston JA, Offord KP. Hurt RD, et al. Among authors: durcan mj. Addict Behav. 2002 Jul-Aug;27(4):493-507. doi: 10.1016/s0306-4603(01)00188-5. Addict Behav. 2002. PMID: 12188588 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters